Jalouli MM, Jalouli J, HassŽus B, …hman J, Hirsch JM, Sand L. Nested PCR for detection of HSV-1 in oral mucosa. Med Oral Patol Oral Cir Bucal. 2015 Nov 1;20 (6):e664-9.  

 

 

doi:10.4317/medoral.20630

http://dx.doi.org/doi:10.4317/medoral.20630

 

 

1. Bettendorf O, Piffko J, Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?. Oral Oncol. 2004;40:110-9.
http://dx.doi.org/10.1016/j.oraloncology.2003.08.010

 

2. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol. 1999;35:173-9.
http://dx.doi.org/10.1016/S1368-8375(98)00101-8

 

3. Reichart PA. Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Investig. 2001;5:207-13.
http://dx.doi.org/10.1007/s00784-001-0132-5

 

4. Meurman JH. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010;46, 411-3.
http://dx.doi.org/10.1016/j.oraloncology.2010.03.003

 

5. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. New Engl J Med. 1999;341:1432-8.
http://dx.doi.org/10.1056/NEJM199911043411904

 

6. Scott DA, Coulter WA, Lamey PJ. Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med. 1997;26:441-7.
http://dx.doi.org/10.1111/j.1600-0714.1997.tb00012.x

 

7. Lou E, Kellman RM, Shillitoe EJ. Effect of herpes simplex virus type-1 on growth of oral cancer in an immunocompetent, orthotopic mouse model. Oral Oncol. 2002;38:349-56.
http://dx.doi.org/10.1016/S1368-8375(01)00069-0

 

8. Zhang DH, Zhang QY, Hong CQ, Chen JY, Shen ZY, Zhu Y. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study. Oncol Rep. 2011;25:1731-8.

 

9. Hirsch JM, Johansson SL, Vahlne A. Effect of snuff and herpes simplex virus-1 on rat oral mucosa: possible associations with the development of squamous cell carcinoma. J Oral Pathol. 1984;13:52-62.
http://dx.doi.org/10.1111/j.1600-0714.1984.tb01400.x

 

10. Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, Galloway DA, et al. Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res. 2001;61:8459-64.

 

11. Parker TM, Smith EM, Ritchie JM, Haugen TH, Vonka V, Turek LP, et al. Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol. 2006;42:288-96.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.003

 

12. Asadi-Amoli F, Heidari AB, Jahanzad I, Jabbarvand M. Detection of human papillomavirus in squamous cell carcinoma of conjunctiva by nested PCR: a case control study in Iran. Acta Medica Iranica. 2011;49:707-14.

 

13. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol. 2004;4:841-55.
http://dx.doi.org/10.1038/nri1485

 

14. Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest. 2004;114:1209-21.
http://dx.doi.org/10.1172/JCI200423395

 

15. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4+CD25+ regulatory T cells control the severity of viral immuno-inflammatory lesions. J Immunol. 2004;172:4123-32.
http://dx.doi.org/10.4049/jimmunol.172.7.4123

 

16. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol. 2002;38:227-34.
http://dx.doi.org/10.1016/S1368-8375(01)00098-7

 

17. van Benthem BH, Spaargaren J, van Den Hoek JA, Merks J, Coutinho RA, Prins M. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect. 2001;77:120-4.
http://dx.doi.org/10.1136/sti.77.2.120

 

18. Miller CS, Danaher RJ. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:43-50.
http://dx.doi.org/10.1016/j.tripleo.2007.06.011

 

19. Meurman JH. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010;46;411-3.
http://dx.doi.org/10.1016/j.oraloncology.2010.03.003

 

20. Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, Galloway DA, et al. Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res. 2001;61:8459-64.

 

21. Parker TM, Smith EM, Ritchie JM, Haugen TH, Vonka V, Turek LP, et al. Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol. 2006;42:288-96.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.003

 

22. Parker TM, Smith EM, Ritchie JM, Haugen TH, Vonka, V, Turek LP, et al. Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol. 2006;42:288-96.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.003

 

23. Jalouli J, Jalouli MM, Sapkota D, Ibrahim SO, Larsson PA, Sand L. Human papilloma virus, herpes simplex virus and Epstein–Barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res. 2012;32:571-80.

 

24. Sand L, Jalouli J. Viruses and oral cancer. Is there a link?. Microbes Infect. 2014;16:371-8.
http://dx.doi.org/10.1016/j.micinf.2014.02.009

 

25. Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Larsson PA, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol. 2010;130:1306-11.
http://dx.doi.org/10.3109/00016481003782041

 

26. Jalouli J, Ibrahim SO, Sapkota D, Jalouli MM, Vasstrand EN, Hirsch JM, et al. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. J Oral Pathol Med. 2010;39:599-604.
http://dx.doi.org/10.1111/j.1600-0714.2010.00910.x

 

27. Sun Y, Chan RK, Tan SH, Ng PP. Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR. J Med Virol 2003;71:423-8.
http://dx.doi.org/10.1002/jmv.10502